News
Anpac Bio has announced that their cancer differentiation analysis (CDA) liquid biopsy test is now capable of detecting 26 different cancers from a single blood test.
--AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States, announced today its joint technical paper on novel Cancer Differentiation Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback